Role of adalimumab in the management of children and adolescents with juvenile idiopathic arthritis and other rheumatic conditions
Katherine Anne B MarzanDivision of Rheumatology, Children's Hospital Los Angeles, Los Angeles, CA, USAAbstract: Treatment of children and adolescents with juvenile idiopathic arthritis and other pediatric rheumatic diseases has evolved. Where once there was only a limited arsenal of medicati...
Saved in:
Main Author: | Marzan KA (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2012-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ADALIMUMAB IN TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: R. V. Denisova, et al.
Published: (2013) -
PHARMACOECONOMIC ISSUES OF ADALIMUMAB THERAPY IN JUVENILE IDIOPATHIC ARTHRITIS
by: K. Simpson, et al.
Published: (2012) -
EFFICACY OF ADALIMUMAB IN A PATIENT WITH JUVENILE IDIOPATHIC ARTHRITIS AND UVEITIS
by: L. A. Galstyan, et al.
Published: (2012) -
Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
by: Alpigiani MG, et al.
Published: (2008) -
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
by: Sofia Lanz, et al.
Published: (2021)